ABSTRACT
INTRODUCTION
Discriminating correctly between benign and malignant adnexal masses is pivotal to planning optimal management. If the cyst is benign, minimally invasive surgery is possible. Recently, it was reported that an ultraminimally invasive technique, with 'needleoscopic' instruments, can be used for surgical removal and staging of borderline tumors 1 . However, spillage of cyst fluid into the peritoneal cavity should be avoided in early-stage ovarian cancer, because it might worsen the prognosis 2 . Moreover, in case of malignancy, survival is higher if the patient is treated in an oncology center 3 .
Transvaginal ultrasound is an excellent tool with which to distinguish malignant from benign adnexal lesions. By assessing subjectively the ultrasound features of an adnexal mass, i.e. by using pattern recognition, an experienced ultrasound examiner can discriminate between benign and malignant adnexal masses, with a sensitivity of 88-96% and a specificity of 90-96% [4] [5] [6] [7] . However, some adnexal masses are difficult to classify, even for a very experienced examiner [8] [9] [10] . Cysts with one cyst locule and papillations but no other solid components are particularly difficult to classify 8 . Papillations are characteristic of borderline tumors [11] [12] [13] and Stage-I epithelial ovarian cancers 8, 14 but are also seen in serous cystadenomas and cystadenofibromas 8, 15 . This may explain why, in a study by Valentin et al. 8 , even experienced ultrasound examiners felt uncertain about the correct diagnosis in 66% of unilocular-solid cysts with papillations but no other solid components, but in only 34% of other types of tumor.
The aim of this study was to identify any ultrasound characteristics of the papillations themselves or of the cyst wall that can help to discriminate between benign and malignant unilocular-solid cysts with papillations but no other solid components.
METHODS

Study population
Patients with an adnexal lesion, described at ultrasonography as a unilocular-solid cyst with papillations but no other solid components, were identified from the International Ovarian Tumor Analysis (IOTA) databases Phases 1, 1b, 2 and 3 7, [16] [17] [18] [19] . Patients were eligible for inclusion in this retrospective study if they had undergone a preoperative ultrasound examination in one of seven ultrasound centers participating in the IOTA studies (Appendix 1). Between 1999 and 2007 or 2009 and 2012, all patients had undergone a transvaginal ultrasound examination which followed a strict research protocol and for which standardized terminology was used to describe the findings 20 . All examinations were performed within 120 days before surgery. A transabdominal scan had also been performed when needed. The reference standard was the histopathological diagnosis provided by the center in which the patient underwent surgery. Tumors were classified according to the criteria recommended by the International Federation of Gynecology and Obstetrics 21 . Borderline tumors were classified as malignant.
Ultrasound features
For this study, we used the information on four of the grayscale and color Doppler ultrasound features of the lesions and papillations, which had been collected prospectively and were available in the IOTA databases. This means that, in all cases, the IOTA definition of papillation was used: a protrusion of solid tissue into the cyst cavity with height ≥ 3 mm 20 . Papillations differ from other solid components, in that they protrude into the cyst cavity while other solid components do not (Figure 1 ). Seven ultrasound features other than those recorded in the IOTA database were also assessed. These were defined a priori by members of the IOTA Steering Committee (D.T., L.V., A.T., T.B.) and the principal investigators in the seven participating centers, both according to their personal experience/judgement and based on evidence from current scientific literature on the subject 15, 22, 23 . Information on these additional ultrasound features was obtained by a single investigator (C.L.), after adequate training with an expert ultrasound operator (D.T.), by reviewing stored electronic and paper ultrasound images. Whilst doing so, she was blinded to clinical information and the histological diagnosis.
In total, therefore, 11 ultrasound features of papillations and the cyst wall were evaluated for each unilocular cyst with papillations, as follows. (1) Number of papillations (one, two, three or more than three). as smooth (Figure 2 ). Information on papillation contour collected prospectively was available in the databases of IOTA Phases 1, 1b and 2; for masses included in IOTA Phase 3, this information was retrieved retrospectively from ultrasound images. (5) Dissemination of papillations, estimated as < 25%, between 25% and 50%, or > 50% of the inner cyst wall covered by papillations. Dissemination was estimated using the ultrasound image in which the papillations seemed to occupy the largest circumference of the cyst wall ( 
Statistical analysis
The statistical significance of differences in categorical data was calculated using the chi-square test or Fisher's exact test and that of differences in continuous data using the Mann-Whitney U-test. Multivariate logistic regression was used for building a model to predict malignancy in unilocular-solid cysts with papillations but no other solid components. We applied two methods of variable selection: stepwise variable selection and calculating the likelihood score chi-square statistic for all possible subsets of explanatory variables. We plotted receiver-operating characteristics (ROC) curves and calculated the area (with 95% CI) under the ROC curve (AUC) to estimate the discriminative performance of the models and to determine mathematically the best cut-off value to predict malignancy. This value corresponded to the point on the ROC curve situated farthest from the reference line. The method proposed by DeLong et al. 24 was used to determine if differences between AUCs were statistically significant. Additionally, the sensitivity, specificity and positive (LR+) and negative (LR-) likelihood ratios associated with the best cut-off were calculated. The 95% CIs for sensitivity and specificity were calculated using Wilson's method 25 . The 95% CIs for LR+ and LR− were calculated using the method of Simel et al. 26 . All statistical analyses were performed using SAS (Statistical Analysis Software) version 9.4 (SAS Institute Inc., Cary, NC, USA). 
RESULTS
In the IOTA databases we found 339 lesions classified as unilocular-solid cysts with papillations but no other solid components at ultrasonography. Of these, 93 were excluded because no ultrasound images were available, 21 because of the poor quality of the available ultrasound images and 21 because other solid components in addition to papillations were confirmed to be present after reviewing the images. This resulted in inclusion of 204 masses. Of these, 37 had been examined in IOTA Phase 1; 34 in Phase 1b; 55 in Phase 2; and 78 in Phase 3. Their histological diagnoses are shown in Table 1 . One hundred and thirty-one (64.2%) cysts were benign, 42 (20.6%) were borderline tumors, 30 (14.7%) were primary invasive tumors and one (0.5%) was a metastasis.
The associations between ultrasound features and histological outcome are shown in Table 2 . With the exception of papillary angle, all ultrasound features of the papillations differed significantly between benign and malignant lesions. Acoustic shadows behind papillations, hyperechoic papillations and hyperechoic foci in the papillations or in the cyst wall were more common in benign than in malignant lesions. Malignant lesions contained a larger number of papillations than did benign lesions, and the papillations in malignant lesions were larger. Vascularized papillations, confluent papillations, papillations with irregular contour and those with internal anechoic spaces were more common in malignant than in benign lesions, and the papillations were more often highly disseminated (i.e. dissemination ≥ 25%) in the malignancies. In a separate analysis, we found that the ultrasound features of borderline tumors overlapped extensively with those of early-(Stage I) and advanced-stage invasive malignancies, so that a distinction between these three entities was not possible.
Using multivariate logistic regression, two models to predict malignancy could be created (Table 3) . Each model contained four variables and they had similar ability to discriminate between benign and malignant unilocular-solid cysts with papillations but no other solid components: AUC, 0.92 (95% CI, 0.88-0.96) vs 0.91 (95% CI, 0.87-0.95), P = 0.29 (Table 4 and Figure 10 ). Both models included the following variables: height of the largest papillation, detectable blood flow in papillations and shadows behind papillations. In one model (Model A), the fourth variable was papillation confluence, and in the other (Model B), it was dissemination of papillations. Using both papillation dissemination and papillation confluence as variables in the same model did not improve Sensitivity, specificity and positive (LR+) and negative (LR-) likelihood ratios were calculated using probability cut-off of 0.360 for predicting malignancy with Model A and 0.207 for predicting malignancy with Model B. AUC, area under receiver-operating characteristics curve. 
DISCUSSION
Our results show that the sonographic appearance of papillations can help to discriminate between benign and malignant unilocular-solid cysts with papillations but no other solid components. The key findings were that the larger the height of the largest papillation and the more disseminated the papillations, the higher the risk of malignancy; detectable blood flow in papillations and confluent papillations are also associated with increased risk, while acoustic shadows behind papillations are associated with decreased risk.
A strength of our study is that it was multicenter and that all patients were recruited prospectively and examined following a detailed research protocol using standardized measurement techniques and standardized terms and definitions to describe the ultrasound images. Moreover, we collected information on a large number of ultrasound features in a relatively large sample. The main limitation of our study is that information on some of the ultrasound variables was collected retrospectively from ultrasound images. It is likely that the echogenicity and contour (smooth or irregular) of papillations, as well as papillary dissemination and confluence, could be judged with reasonable certainty from ultrasound images, if we assume that the images were representative. However, in our opinion, assessment of the papillary angle is not reliable either in prospective or retrospective studies. This angle is difficult to standardize as it changes according to the orientation of the probe, and also because there may be different papillations with different angles. Therefore, we believe that the retrospective design of our study had no major impact on the results for papillary angle. However, because the ultrasound images were not collected with the specific aim of showing whether or not there were acoustic shadows behind papillations, anechoic spaces within papillations, or hyperechoic foci in papillations or in the cyst wall, the prevalence of these features may have been underestimated. Another limitation is that the patients included in this study were examined over a long period of time (from 1999 to 2007 and 2009 to 2012) and by many different sonologists. During this 13-year recruitment period, ultrasound equipment changed and the quality of ultrasound images improved. This, as well as differences in image interpretation between sonologists, could have affected our results to some degree.
To the best of our knowledge there is only one published study reporting which clinical and ultrasound variables can be used to distinguish benign from malignant unilocular-solid cysts with papillations but no other solid components 8 . Two other studies investigated the possibility of using the sonographic appearance of papillations to discriminate between benign and malignant tumors, but one of them included unilocular-solid cysts not only with papillations but also with other solid components 22 and the other study also included lesions containing both septa and solid components other than papillations 23 . The details of these three studies 8, 22, 23 are summarized in Table 5 . In general, our findings agree with the results of these previous three studies. It seems that the larger and more numerous (disseminated) the papillations the higher the risk of malignancy, that papillations vascularized on color or power Doppler are associated with increased risk of malignancy, and that shadows behind hyperechoic foci in the papillations or in the cyst wall, or shadows behind the papillations themselves, are associated with decreased risk. In our study, the number of papillations was not retained in the multivariable logistic regression model, while confluent papillations and the degree of dissemination were. This is probably because of covariation between the number of papillations and dissemination and confluence of papillations. The finding that shadows behind papillations are associated with benign tumors is in agreement with the results of Goldstein et al. 15 , who found that hyperechoic papillations with acoustic shadows behind them were common in cystadenofibromas. Unilocular-solid cysts with papillations but no other solid components comprise only 7% of all adnexal lesions 8 , but it is clinically challenging to manage them, because it is difficult to exclude malignancy in such masses. Most unilocular-solid cysts with papillations but no other solid components are benign (64% in our population, in agreement with Valentin et al. 8 , who reported a percentage of 65%) and some might not need surgical removal unless they cause symptoms. A substantial proportion consists of borderline tumors that can be managed with conservative surgery in women who wish to preserve their fertility. Some are invasively malignant tumors that require more extensive surgery, preferably in a gynecological oncology center. In this work, we have identified ultrasound features that are apparently useful to predict malignancy in unilocular-solid cysts with papillations but no other solid components.
Clinically, it is important to be able to discriminate preoperatively between borderline tumors and early-stage and advanced-stage invasive ovarian malignancies, because they require different treatment and have different prognoses. Unfortunately, however, we found that the three entities cannot be distinguished by using the ultrasound features that we investigated in this study. It would be of interest to investigate if novel biomarkers [27] [28] [29] [30] can be used to indicate malignancy in unilocular-solid cysts with papillations but no other solid components.
Our results provide novel insights into morphological markers that may help us to manage a particularly difficult group of adnexal masses, but they need to be confirmed in prospective studies.
